Repository
Publications
Prognostic stratification of patients with biliary tract cancer treated with chemoimmunotherapy: A retrospective multicenter real-world studyPersano M, Casadei-Gardini A, Fornaro L, Satake T, Abidoye O, Lo Prinzi F, Antonuzzo L, Kim JW, Bergamo F, Bathon M, Saborowski A, Pressiani T, Vivaldi C, Rapposelli IG, Peeters F, Braconi C, Pinato DJ, Tamburini E, Niger M, Tamberi S, Castet F, Verrico M, Parisi A, Couto N, Chon HJ, Lamarca A, Giordano G, Finkelmeier F, Oneda E, Avallone A, Perkhofer L, Kim IH, Garajova I, Corallo S, Fenocchio E, Dell'Aquila E, Pirrone C, Lucidi L, Tesini G, Valenzi E, Diana A, Yoo C, Schirripa M, Formica V, Rodriquenz MG, Scartozzi M, Adeva J, Ghidini M, Prager GW, Aprile G, Spinelli GP, Yung-Yeh S, Chan SL, Ikeda M, Bekaii-Saab T, Lucchetti J, Lavacchi D, Kang M, Balsano R, Salani F, Camera S, Masi G, Lonardi S, Vogel A, Rimassa L, Rimini M.
|
Ultra-low-pass whole-genome sequencing of bile cfDNA in patients with biliary stricturesRojo C, Rullan M, Sogbe M, Herranz JM, Elizalde M, Oyón D, Vila JJ, Purroy A, Azkona M, Marchese FP, Krawczyk M, Fernández-Barrena MG, Sangro B, Argemi J, Urmán J, Ávila MA, Berasain C, Arechederra M.
|
Chronic liver disease is associated with earlier-stage cholangiocarcinoma diagnosis and improved prognosis: Findings from the GLOBAL-BTC registryIzquierdo-Sanchez L, Narbaiza J, Martin-Robles J, Lamarca A, Klümpen HJ, La Casta A, Valsan A, Roessler S, Braconi C, da Fonseca LG, Dopazo C, Juliebø AT, Mauro E, Buettner S, Balderramo D, Ponz-Sarvise M, Ferrer JD, Zieniewicz K, Utpatel K, Sparchez Z, Brustia R, Peck-Radosavljevic M, De Sario G, Gómez-Gavara C, Carrilho FJ, Tesini G, Nair P, Gutierrez E, Zonderhuis BM, Koerkamp BG, Forner A, Folseraas T, Goeppert B, Pavithran K, Bujanda L, Erdmann JI, Valle JW, Banales JM; Global Biliary Tract Cancer Registry Study Group.
|
Bile extracellular vesicles for early cholangiocarcinoma detection in primary sclerosing cholangitisLapitz A, Grimsrud MM, Catanzaro E, Rodrigues PM, Hov JR, Azkargorta M, Val B, Vesterhus M, Grzyb K, Reims HM, Elortza F, Izquierdo-Sánchez L, Perugorria MJ, Bujanda L, Aabakken L, Paulsen V, Karlsen TH, Banales JM, Folseraas T.
|
Outcomes of Cisplatin, Gemcitabine, and Durvalumab According to TOPAZ-1 Study Eligibility: A Large Global Analysis in a Real-World SettingPrinzi FL, Rimini M, Ikeda M, Abidoye O, Lucchetti J, Antonuzzo L, Kim JW, Nichetti F, Saborowski A, Pressiani T, Vivaldi C, Rapposelli IG, Peeters F, Braconi C, Pinato DJ, Tamburini E, Pircher C, Tamberi S, Castet F, Verrico M, Parisi A, Couto N, Chon HJ, Martirena A, Lamarca A, Landriscina M, Finkelmeier F, Oneda E, Avallone A, Dell'Aquila E, Perkhofer L, Kim IH, Formica V, de Sousa Pinto CM, Garajova I, Kang B, Corallo S, Fenocchio E, Farinea G, Pastorino A, Diana A, Changhoon Y, Schirripa M, Rodriquenz MG, Scartozzi M, Zumstein L, Ghidini M, Prager GW, Aprile G, Spinelli GP, Yung-Yeh S, Chan SL, Warmington E, Lancianese A, Satake T, Bekaii-Saab T, Giordano G, Lavacchi D, Passeri L, Ferrara M, Kang M, Prete AA, Bozzarelli S, Persano M, Masi G, Balsano R, Niger M, Lonardi S, Salani F, Camera S, Vogel A, Fornaro L, Rimassa L, Casadei-Gardini A.
|
